Back to search

Article

Designing and Resourcing European Medical Affairs Under the EU HTA Regulation: A Market Complexity Index for Hub-and-Spoke Structures

2026-06-23

Abstract excerpt

<title>Abstract</title> <p>Pharmaceutical companies expanding into Europe face regulatory and market access heterogeneity unmatched in any other region. The EU Health Technology Assessment Regulation, operational since 12 January 2025, compounds it: Joint Clinical Assessments are now conducted at European level while national pricing and reimbursement authority persists, creating a dual-layer organizational deman...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c18906a8-8de7-53be-9122-c5347e07eb45
DOI
10.21203/rs.3.rs-9952134/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Designing and Resourcing European Medical Affairs Under the EU HTA Regulation: A Market Complexity Index for Hub-and-Spoke StructuresDOI 10.21203/rs.3.rs-9952134/v1
How the HTAR will contribute to a value-based decision making for medicinal products across the EUSemantic proximity
Launch Sequencing of Pharmaceuticals with Multiple Therapeutic Indications: Evidence from Seven CountriesSemantic proximity
A Decade of Innovation: Medicinal Products with New Active Substances Centrally Authorized Within EU Between 2011 and 2020Semantic proximity
Innovation Institutions and COVID-19, Part IISemantic proximity
Quantifying the Dual Value and Governance Risks of Early Access Programs in Oncology: A Single-Centre Analysis and National Policy FrameworkSemantic proximity
Innovation Institutions and COVID-19Semantic proximity
Time to Patients’ Access to New Medicines in Greece: Evaluation of Health Technology Assessment (HTA) Process from July 2018 until January 2021.Semantic proximity
Point-in-time evidence and cross-area clinical precedent anticipate clinical entry across 100 focal areas: retrospective validation of the Intangia triage layerSemantic proximity
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology TrialsSemantic proximity
Relationship and factors of technical efficiency and quality of hospital care: the federal state system of GermanySemantic proximity
Operationalisation of the African Medicines Agency: Retrospective evaluation of the continental centralized pilot procedure – timelines to recommendation and national registration decisionsSemantic proximity
Integrating Environmental, Social, and Governance Factors in Megaproject Front-End Design: A Quantitative Framework with Prediction and Uncertainty AssessmentSemantic proximity
Select a neighboring publication to make it the new centre.